SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Monsanto Co.
MTC 2.305+9.2%Nov 21 9:30 AM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Dan Spillane who wrote (508)11/11/1998 7:09:00 PM
From: nickscores  Read Replies (1) of 2539
 
I agree. However, I am concerned that the street will view the issuance of new stock as dilutive to earnings and we may have more short term price pressure. I hope not, but. Most people will consider that to raise $1billion from the sale of stock, Monsanto will have to issue about 25 million shares - they will view that as negative and stop there. However, 25 million shares is just a drop in the bucket of 600 million shares currently outstanding. In fact, 25 million shares represents only a 4% increase in total shares issued - hardly enough to be considered dilutive. Still, who knows how people will react to the news. It wasn't rational to punish Monsanto for the failed AHP merger, so......
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News